WO2002077231A3 - Nucleic acid-associated proteins - Google Patents

Nucleic acid-associated proteins Download PDF

Info

Publication number
WO2002077231A3
WO2002077231A3 PCT/US2001/043606 US0143606W WO02077231A3 WO 2002077231 A3 WO2002077231 A3 WO 2002077231A3 US 0143606 W US0143606 W US 0143606W WO 02077231 A3 WO02077231 A3 WO 02077231A3
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
associated proteins
naap
provides
polynucleotides
Prior art date
Application number
PCT/US2001/043606
Other languages
French (fr)
Other versions
WO2002077231A2 (en
Inventor
Y Tom Tang
Bridget A Warren
April J A Hafalia
Chandra Arvizu
Dyung Aina M Lu
Vick S Elliott
Yuming Xu
Preeti G Lal
Henry Yue
Original Assignee
Incyte Genomics Inc
Y Tom Tang
Bridget A Warren
April J A Hafalia
Chandra Arvizu
Dyung Aina M Lu
Vick S Elliott
Yuming Xu
Preeti G Lal
Henry Yue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Genomics Inc, Y Tom Tang, Bridget A Warren, April J A Hafalia, Chandra Arvizu, Dyung Aina M Lu, Vick S Elliott, Yuming Xu, Preeti G Lal, Henry Yue filed Critical Incyte Genomics Inc
Priority to US10/416,592 priority Critical patent/US20040053291A1/en
Publication of WO2002077231A2 publication Critical patent/WO2002077231A2/en
Publication of WO2002077231A3 publication Critical patent/WO2002077231A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6875—Nucleoproteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention provides human nucleic acid-associated proteins (NAAP) and polynucleotides which identify and encode NAAP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for diagnosing, treating, or preventing disorders associated with aberrant expression of NAAP.
PCT/US2001/043606 2000-11-13 2001-11-13 Nucleic acid-associated proteins WO2002077231A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/416,592 US20040053291A1 (en) 2001-11-13 2001-11-13 Nucleic acid-associated proteins

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US24840400P 2000-11-13 2000-11-13
US60/248,404 2000-11-13
US24982500P 2000-11-16 2000-11-16
US60/249,825 2000-11-16

Publications (2)

Publication Number Publication Date
WO2002077231A2 WO2002077231A2 (en) 2002-10-03
WO2002077231A3 true WO2002077231A3 (en) 2003-05-01

Family

ID=26939329

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043606 WO2002077231A2 (en) 2000-11-13 2001-11-13 Nucleic acid-associated proteins

Country Status (1)

Country Link
WO (1) WO2002077231A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0609119D0 (en) 2006-05-09 2006-06-21 Univ Birmingham Histones

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044063A2 (en) * 1998-02-25 1999-09-02 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Tumor tissue microarrays for rapid molecular profiling

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999044063A2 (en) * 1998-02-25 1999-09-02 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Tumor tissue microarrays for rapid molecular profiling

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] EBI, Hinxton UK; 15 September 1999 (1999-09-15), "Homo sapiens chromosome 19 clone CTD-2192J16, complete sequence.", XP002220398, Database accession no. AC010422 *
VISSING H ET AL: "Repression of transcriptional activity by heterologous KRAB domains present in zinc finger proteins.", FEBS LETTERS, vol. 369, no. 2-3, 1995, pages 153 - 157, XP002220397, ISSN: 0014-5793 *

Also Published As

Publication number Publication date
WO2002077231A2 (en) 2002-10-03

Similar Documents

Publication Publication Date Title
WO2004087875A3 (en) Nucleic acid-associated proteins
WO2003094848A3 (en) Nucleic acid-associated proteins
WO2001096546A3 (en) Protein phosphatases
WO2002026950A3 (en) Transferases
WO2002097060A3 (en) Carbohydrate-associated proteins
WO2002034783A3 (en) Transmembrane proteins
WO2002010363A3 (en) Protein phosphatases
WO2003054219A3 (en) Nucleic acid-associated proteins
WO2001085942A3 (en) Cytoskeleton-associated proteins
WO2003076586A3 (en) Nucleic acid-associated proteins
WO2003038052A3 (en) Nucleic acid-associated proteins
WO2002024924A3 (en) Protein phosphatases
WO2002002757A3 (en) Adenylyl and guanylyl cyclases
WO2001083524A3 (en) Rna metabolism proteins
WO2002066646A3 (en) Neurotransmission-associated proteins
WO2003010329A3 (en) Nucleic acid-associated proteins
WO2002099115A3 (en) Nucleic acid-associated proteins
WO2003016549A3 (en) Nucleic-acid associated proteins
WO2003006618A3 (en) Nucleic acid-associated proteins
WO2002040671A3 (en) Immunoglobulin superfamily proteins
WO2000023466A3 (en) Human rna binding proteins
WO2002079389A3 (en) Nucleic acid-associated proteins
WO2003052048A3 (en) Nucleic acid-associated proteins
WO2003000864A8 (en) Nucleic acid-associated proteins
WO2002072630A3 (en) Nucleic acid-associated proteins

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 10416592

Country of ref document: US

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP